Both genetic, including mutations in tumor suppressor genes such as TP53 and NFE2L2 [11, 12], and epigenetic alterations, including DNA methylation and non-coding RNAs [13–15], have been uncovered to play pivotal roles in the tumorigenesis and development of ESCC. Here, TP53 is linked to esophageal squamous cell carcinoma.